Moonlight Bio
Amanda Balboni Iniguez, PhD, currently serves as Vice President of Research & Development at Moonlight Bio, a biotech company focused on innovative T cell therapies for cancer treatment. Prior experience includes roles as Associate Director at 2seventy bio, managing the development of a next-generation CAR T cell therapy for acute myeloid leukemia, and Associate Director and Senior Scientist at bluebird bio, where Amanda led teams in the identification and evaluation of TCR and CAR therapies for various malignancies. Amanda's academic background includes a postdoctoral fellowship at Harvard Medical School and a PhD in Cancer Biology from the Geisel School of Medicine at Dartmouth. With additional experience in research and development at institutions such as the Dana-Farber Cancer Institute and Archemix, Amanda has established a robust career dedicated to advancing cancer therapeutics.
Moonlight Bio
Moonlight Bio is a Seattle-based, preclinical stage biotech company pioneering the development of cutting-edge cell therapies for the treatment of cancer. Our team is comprised of highly collaborative individuals who are passionate about designing highly innovative technologies and candidates with the potential to transform the lives of cancer patients. Engaging across the full landscape of drug development, Moonlight’s team members are pursuing opportunities in discovery research, component design and screening, preclinical modeling, process and analytical development, translational and clinical studies, and partnerships necessary to enable and advance our core technologies. We believe in fostering a healthy work-life balance, and when we’re not busy in the lab, we enjoy the natural beauty and recreational activities that the Pacific Northwest has to offer. We love to collaborate! Reach out to us: info@moonlightbio.us